Zelos Therapeutics specializes in the development of innovative treatments for bone disorders and related indications in large, underserved markets.

Zelos Therapeutics' product candidate ZT-031 is available for licensing.  More information is available HERE.

For matters relating to the nasal spray formulation (ZT-034), a nasal spray formulation of teriparatide (PTH1-34) for osteoporosis, please refer to WWW.AZELON.COM